MYRIAD GENETICS INC — Director's Dealing 2014

Apr 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-04-07

Reporting Person: Hart Jayne B. (Executive VP Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-07	Common Stock	M	17500.0	$27.07	Acquired	18430	Direct
2014-04-07	Common Stock	S	17500.0	$40.897	Disposed	930	Direct
2014-04-07	Common Stock	M	3500.0	$23.98	Acquired	4430	Direct
2014-04-07	Common Stock	S	3500.0	$40.897	Disposed	930	Direct
2014-04-07	Common Stock	M	28000.0	$19.47	Acquired	28930	Direct
2014-04-07	Common Stock	S	28000.0	$40.897	Disposed	930	Direct
2014-04-07	Common Stock	M	21966.0	$24.89	Acquired	22896	Direct
2014-04-07	Common Stock	S	21966.0	$40.897	Disposed	930	Direct
2014-04-07	Common Stock	M	8034.0	$24.89	Acquired	8964	Direct
2014-04-07	Common Stock	S	8034.0	$40.897	Disposed	930	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-07	Incentive Stock Option (right to buy)	$24.89	M	8034.0	Disposed	2021-05-25	Common Stock (8034)	Direct
2014-04-07	Non-Qualified Stock Option (right to buy)	$19.47	M	28000.0	Disposed	2021-09-13	Common Stock (28000)	Direct
2014-04-07	Non-Qualified Stock Option (right to buy)	$23.98	M	3500.0	Disposed	2022-03-07	Common Stock (3500)	Direct
2014-04-07	Non-Qualified Stock Option (right to buy)	$24.89	M	21966.0	Disposed	2021-05-25	Common Stock (21966)	Direct
2014-04-07	Non-Qualified Stock Option (right to buy)	$27.07	M	17500.0	Disposed	2022-09-12	Common Stock (17500)	Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.